Work

Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS study

Year: 2026

Type: article

Study design: Observational Study

Source: Multiple Sclerosis Journal

DOI: 10.1177/13524585251412125

Authors: Kiranpal Singh Sangha, Collin Jakubecz, Michelle Maynard, Roberto S Hernandez, Sara Esmaeili, Aram Zabeti, Hesham Abboud, Alessandro Serra, Sophia Woodson, Ahmed Z Obeidat

Institutions: University of Cincinnati, University of Cincinnati Medical Center, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Medical College of Wisconsin, The University of Texas Southwestern Medical Center, Case Western Reserve University

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7128520124

FWCI: 26.77

Cites: 13

Cited by: 6

Related to: